Related Experiment Video
Updated: Aug 15, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Incidence and predictors of cardiac perforation after permanent pacemaker placement
Srijoy Mahapatra1, Kevin A Bybee, T Jared Bunch
1Division of Cardiology, Mayo Clinic, Rochester, Minnesota 55902, USA.
Insights
Pericardial effusion after pacemaker implantation is rare. Avoiding temporary pacemakers and careful steroid use can minimize risks of this cardiac perforation complication.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
- Medical Device Complications
Background:
- Pericardial effusion can indicate cardiac perforation following permanent pacemaker (PPM) implantation.
- Risk factors for developing post-PPM effusion remain unevaluated.
Purpose of the Study:
- To identify predictors of symptomatic pericardial effusion after PPM placement.
- To evaluate risk factors associated with post-pacemaker cardiac perforation.
Main Methods:
- Cross-referencing Mayo Clinic pacemaker and echocardiogram databases (1995-2003).
- Analyzing 4,280 PPM implantations, identifying 50 (1.2%) patients with significant effusion.
- Matching affected patients with 100 controls without effusion.
Main Results:
- Concomitant temporary transvenous pacemaker use (HR 2.7) and pre-implant steroid use (HR 3.2) were significant multivariate predictors of effusion.
- Helical screw leads (HR 2.5) also increased risk, while higher right ventricular systolic pressure (>35 mmHg) was protective (HR 0.70).
- Lower BMI (<20), older age, and longer fluoroscopy times were weaker predictors.
Conclusions:
- The incidence of post-implant pericardial effusion is low.
- Minimizing effusion risk involves avoiding unnecessary temporary pacemaker placement.
- Caution is advised with steroid use in patients undergoing permanent pacemaker implantation.
Background:
Pericardial effusion, a sign of cardiac perforation, may complicate permanent pacemaker placement. Risk factors for development of post-permanent pacemaker effusion have not been evaluated.
Objectives:
The purpose of this study was to determine the predictors of symptomatic pericardial effusion after permanent pacemaker placement.
Methods:
The Mayo Clinic pacemaker and echocardiogram databases were cross-referenced. From 1995 to 2003, 4,280 permanent pacemakers were implanted. Fifty (1.2%) patients developed significant effusion and symptoms consistent with perforation. They were randomly matched with 100 patients without effusion after permanent pacemaker placement.
Results:
The strongest predictors of postimplant effusion by univariate analysis were the concomitant use of a temporary transvenous pacemaker (hazard ratio [HR] 3.2, 95% confidence interval [CI] 1.6-6.2, P = .001) or steroid use within 7 days prior to implant (HR 4.1, 95% CI 1.1-10, P = .003). Weaker predictors were use of helical screw ventricular leads, body mass index (BMI) <20, older age, and longer fluoroscopy times. Variables associated with lower risk of perforation were right ventricular systolic pressure >35 mmHg (HR 0.70, 95% CI 0.44-0.97, P = .01) or BMI >30 (HR 0.62, 95% CI 0.41-0.93, P = .01). Multivariate predictors were use of temporary pacemaker (HR 2.7, 95% CI 1.4-3.9, P = .01), helical screw leads (HR 2.5; 95% CI 1.4-3.8, P = .04), and steroids (HR 3.2, 95% CI 1.1-5.4, P = .04). Right ventricular systolic pressure >35 mmHg was the only protective factor (HR 0.70, 95% CI 0.50-0.92, P = .02).
Conclusion:
The incidence of postimplant effusions is low. In order to minimize periprocedural permanent pacemaker effusions, temporary pacemaker placement should be avoided unless essential, and particular care should be taken when placing a permanent pacemaker in patients who are taking steroids.
Related Concept Videos
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Cardiac Catheterization II: Right Heart Catheterization
Pericarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
